ANPI Angiotech Pharmaceuticals - Common Shares (MM)

DALLAS, Dec. 27 /PRNewswire/ -- Beacon Equity Research announces the availability of TraderNotes on stocks that are making news today. Investors can view all of the daily trading notes for free by visiting: http://www.beaconequityresearch.com/ Today's TraderNotes include: Lantis Laser Inc. (Pink Sheets: LLSR), Paradigm Medical Industries, Inc. (OTC:PMED) (BULLETIN BOARD: PMED) , Angiotech Pharmaceuticals, Inc. (NASDAQ:ANPI), Pfizer Inc. (NYSE:PFE), Schering-Plough Corporation (NYSE:SGP) Today's TraderNotes highlights Lantis Laser, Inc., a company developing and commercializing advanced technologies for applications in dentistry and which has exclusive rights to the application of Optical Coherence Tomography (OCT) technology for dental diagnostic imaging. Beacon Research's TraderNotes are brief analyses on the active stocks each day that are affecting the markets. These include breaking news, insider activity, recent 52-week highs/lows, technical breakouts, and other market driving information. Beacon is the authority on research in the small cap sector, and our analysts strive each day to find the stocks that are poised to be the biggest movers before the rest of the market is aware of them. We encourage investors to subscribe to our FREE newsletter filled with daily trading ideas by visiting: http://www.BeaconEquityResearch.com Beacon Equity Research is one of the industry's largest small cap research providers. Beacon strives to provide a balanced view of many promising small cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the publicly available information available on them. For more information on Beacon Research, please visit: http://www.BeaconEquityResearch.com CRD# 2954278 Beacon Equity Research Disclosure The companies that are discussed have not always approved the statements made in this opinion. These reports are for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell any securities mentioned. We are not a licensed or registered broker dealer, investment advisor, analyst or underwriter. Please consult a registered broker before purchasing or selling any securities viewed or mentioned here. Beacon Equity Research and its affiliates have been directly compensated a total of nine thousand dollars directly from Lantis Laser for enrollment of LLSR in its research program. Beacon Equity Research Jeff Bishop, (469)-252-3505 Available Topic Expert(s): For information on the listed expert(s), click appropriate link. JEFF BISHOP http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=70781 DATASOURCE: Beacon Equity Research CONTACT: Jeff Bishop of Beacon Equity Research, +1-469-252-3505, Web site: http://www.beaconequityresearch.com/

Copyright